Ultralife Corporation (ULBI)

Ultralife Corporation is a NASDAQ-listed common stock company that designs, manufactures, installs, and maintains power, communication, and electronics systems for customers around the world. The company operates through two segments: Battery & Energy Products and Communications Systems. Its battery business includes lithium and rechargeable batteries, lithium-ion cells, battery systems, uninterruptable power supplies, and charging equipment for military and commercial uses. The communications segment provides equipment and accessories used in military communications, including amplifiers, power supplies, cable assemblies, mounts, and integrated systems for vehicle, fixed, and man-portable applications. Ultralife sells products under several brands and serves government, defense, industrial, and commercial markets, with some 9-volt batteries also distributed through retail chains and online channels. The company was incorporated in 1990 and is based in Newark, New York.


Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Analyst Target Rating Overall Financial Health Upcoming Dividend Ex-Date Dividend Payment Date Upcoming Dividend Dividend Yield Next Earnings Date P/E Ratio Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Payout Ratio Free Cash Flow / Net Income
NASDAQ-ULBI
$6.83
26.0% Upside
Undervalued
Fair
0.0%
July 23, 2026
-11.0x
0.7x
0.5x
87.781 M
132.3 M
36.6%
57.7%
2.0
-74.6%
Valuation • Fair Value

Ultralife Corporation (NASDAQ-ULBI) Fair Value by Valuation Model

Compare the primary fair value estimate for Ultralife Corporation (NASDAQ-ULBI) with model-based valuation references such as DCF, Ben Graham, DDM, EPV and comparable-company valuation.

Primary Valuation Read

Fair Value

$6.83

Estimated upside of 26.0% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$8.90

Discounted cash flow valuation reference.

Ben Graham Formula Value

$0

Classic Ben Graham valuation formula reference.

DDM Fair Value

NM

Dividend discount model valuation reference.

EPV Fair Value

$4.42

Earnings power value estimate.

Comps Fair Value

$6.55

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use this section to compare the primary fair value estimate for Ultralife Corporation (NASDAQ-ULBI) with several model-based valuation references. Different models can produce different outputs because each method relies on a different set of assumptions, so the primary fair value estimate should be read alongside the model spread rather than in isolation.

Profitability • Growth

Profitability & Growth for Ultralife Corporation (NASDAQ-ULBI)

A compact read on revenue, forward revenue expectations, EBITDA and operating profitability trends.

Revenue

187.9 M

Current operating scale indicator.

Revenue Forecast

224.9 M

Forward revenue estimate.

EBITDA

11.025 M

Current operating profitability reference.

EBITDA Forecast

24.8 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ultralife Corporation (NASDAQ-ULBI) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ultralife Corporation (NASDAQ-ULBI)

Review financial health, earnings quality and balance-sheet risk through Piotroski, Beneish, Altman and cash conversion metrics.

Financial Health

Fair

Mixed or neutral financial-health read.

Piotroski Score

5

Mid-range quality score.

Beneish M-Score

-2.95

No elevated caution signal from this screen.

Altman Z-Score

2.0

Intermediate risk zone.

FCF / Net Income

-74.6%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ultralife Corporation (NASDAQ-ULBI). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ultralife Corporation (NASDAQ-ULBI)

Track the next earnings date, ex-dividend date, dividend payment date, dividend yield and upcoming distribution details where available.

Next Earnings Date

July 23, 2026

Days to Earnings

2

Dividend Payment Date

Not available

Ex-Dividend Date

Not available

Dividend Yield

0.0%

Income yield reference.

Upcoming Dividend

Not available

Data is currently unavailable.

Payment Type

Not available

Data is currently unavailable.

Dividend Currency

Not available

Data is currently unavailable.

Payout Ratio

Not available

Data is currently unavailable.

How to read events and dividends

This section helps investors track time-sensitive items for Ultralife Corporation (NASDAQ-ULBI), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Stock Forecast • Technical Outlook

Ultralife Corporation (NASDAQ-ULBI) Stock Forecast & Technical Outlook

Review Ultralife Corporation (NASDAQ-ULBI) across multiple technical time frames, alongside analyst recommendation data, to form a faster read on market positioning and near-term sentiment.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Neutral

The 15-minute technical read for Ultralife Corporation (NASDAQ-ULBI) is currently Neutral. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Ultralife Corporation (NASDAQ-ULBI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Ultralife Corporation (NASDAQ-ULBI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Ultralife Corporation (NASDAQ-ULBI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Ultralife Corporation (NASDAQ-ULBI) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Analyst Consensus for Ultralife Corporation (NASDAQ-ULBI)

A consolidated view of buy, hold and sell recommendations based on the currently available analyst data.

Strong Sell Sell Neutral Buy Strong Buy
Consolidated analyst recommendation mix
Strong Buy

Based on the available recommendation mix, Ultralife Corporation (NASDAQ-ULBI) has a Strong Buy consensus, with 1 buy, 0 hold and 0 sell recommendations in the current data set.

Buy 1
Hold 0
Sell 0
FAQ Fast Investor Answers

Ultralife Corporation (NASDAQ-ULBI) Stock FAQ

Quick answers about Ultralife Corporation (NASDAQ-ULBI) stock, including fair value, valuation rating, analyst price target, dividends, earnings dates, market capitalization, financial health and other key stock analysis metrics.

Fair Value
$6.83
Estimated upside 26.0%
Valuation Rating
Undervalued
Estimated upside of 26.0%
Analyst Target
Not available
Data is currently unavailable
Financial Health
Fair
Current financial-health read

The current fair value estimate for Ultralife Corporation (NASDAQ-ULBI) is $6.83. This implies an estimated upside of 26.0% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 26.0% versus the current market price.

An analyst price target for Ultralife Corporation (NASDAQ-ULBI) is not currently available in the latest data file.

The current financial health read for Ultralife Corporation (NASDAQ-ULBI) is Fair. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ultralife Corporation (NASDAQ-ULBI) is July 23, 2026.

Based on the current data, dividend yield is 0.0%.

The current P/E ratio listed for Ultralife Corporation (NASDAQ-ULBI) is -11.0x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

The current market capitalization listed for Ultralife Corporation is 87.781 M.

The current enterprise value listed for Ultralife Corporation is 132.3 M. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ultralife Corporation is NASDAQ-ULBI, and the stock is listed on NASDAQ.

Ultralife Corporation (NASDAQ-ULBI) is listed on NASDAQ.

The current debt-to-total-capital ratio listed for Ultralife Corporation is 36.6%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ultralife Corporation is 57.7%. Free float helps investors understand how much of the share base is available for public trading.